LiqTech International (NASDAQ:LIQT – Free Report) had its target price lowered by Ascendiant Capital Markets from $5.15 to $3.20 in a report released on Monday,Benzinga reports. The firm currently has a buy rating on the stock.
LIQT has been the topic of several other research reports. Lake Street Capital decreased their price target on LiqTech International from $9.00 to $6.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. StockNews.com started coverage on LiqTech International in a research report on Wednesday, November 20th. They set a “sell” rating on the stock.
Check Out Our Latest Research Report on LiqTech International
LiqTech International Price Performance
Institutional Trading of LiqTech International
An institutional investor recently raised its position in LiqTech International stock. HighTower Advisors LLC boosted its stake in LiqTech International, Inc. (NASDAQ:LIQT – Free Report) by 40.1% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 38,599 shares of the company’s stock after buying an additional 11,043 shares during the quarter. HighTower Advisors LLC owned approximately 0.66% of LiqTech International worth $99,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 35.06% of the company’s stock.
LiqTech International Company Profile
LiqTech International, Inc, a clean technology company, designs, develops, produces, markets, and sells automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the United States, Canada, Europe, Asia, and South America. The company operates through Water, Ceramics, and Plastics segments.
Further Reading
- Five stocks we like better than LiqTech International
- Insider Buying Explained: What Investors Need to Know
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Profitably Trade Stocks at 52-Week Highs
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Why Invest in 5G? How to Invest in 5G Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for LiqTech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiqTech International and related companies with MarketBeat.com's FREE daily email newsletter.